| Aardvark Therapeutics, Inc. | AARD | Roy D. BaynesDirDERIV | Aug 14 | A | 44,964 | $0.00 | —? |
| Natera, Inc. | NTRA | Roy D. BaynesDir | Jun 26 | A | 75 | — | — |
| Natera, Inc. | NTRA | Roy D. BaynesDir | Jun 26 | A | 1,571 | — | — |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDirDERIV | Jun 12 | MPLAN | 4,500 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDir | Jun 12 | SPLAN | 4,500 | $50.00 | $225K |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDir | Jun 12 | MPLAN | 4,500 | $21.38 | $96K |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDirDERIV | May 19 | A | 12,000 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDir | May 19 | A | 4,000 | $0.00 | — |
| Nurix Therapeutics, Inc. | NRIX | Roy D. BaynesDirDERIV | May 15 | A | 31,250 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDirDERIV | May 5 | MPLAN | 4,500 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDir | May 5 | SPLAN | 4,500 | $46.65 | $210K |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDir | May 5 | MPLAN | 4,500 | $18.27 | $82K |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDirDERIV | May 1 | MPLAN | 9,750 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDir | May 1 | SPLAN | 9,750 | $44.22 | $431K |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDir | May 1 | MPLAN | 9,750 | $6.82 | $66K |
| Natera, Inc. | NTRA | Roy D. BaynesDir | Apr 24 | A | 83 | — | — |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDirDERIV | Apr 14 | MPLAN | 6,750 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDirDERIV | Apr 14 | MPLAN | 4,500 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDirDERIV | Apr 14 | MPLAN | 4,500 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDirDERIV | Apr 14 | MPLAN | 9,000 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDirDERIV | Apr 14 | MPLAN | 8,000 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDir | Apr 14 | SPLAN | 6,750 | $42.12 | $284K |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDir | Apr 14 | SPLAN | 26,000 | $41.07 | $1.1M |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDir | Apr 14 | MPLAN | 6,750 | $17.11 | $115K |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDir | Apr 14 | MPLAN | 4,500 | $21.38 | $96K |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDir | Apr 14 | MPLAN | 4,500 | $18.27 | $82K |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDir | Apr 14 | MPLAN | 9,000 | $15.43 | $139K |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDir | Apr 14 | MPLAN | 8,000 | $17.94 | $144K |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDirDERIV | Apr 6 | MPLAN | 10,000 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDir | Apr 6 | SPLAN | 10,000 | $33.00 | $330K |
| Travere Therapeutics, Inc. | TVTX | Roy D. BaynesDir | Apr 6 | MPLAN | 10,000 | $26.52 | $265K |
| Eikon Therapeutics, Inc. | EIKN | Roy D. BaynesCMODERIV | Mar 2 | A | 134,088 | $0.00 | —? |
| Natera, Inc. | NTRA | Roy D. BaynesDir | Jan 30 | A | 70 | — | — |
| Natera, Inc. | NTRA | Roy D. BaynesDirDERIV | Nov 20 | MPLAN | 7,068 | $0.00 | —? |
| Natera, Inc. | NTRA | Roy D. BaynesDirDERIV | Nov 20 | MPLAN | 600 | $0.00 | —? |
| Natera, Inc. | NTRA | Roy D. BaynesDirDERIV | Nov 19 | MPLAN | 5,112 | $0.00 | —? |
| Natera, Inc. | NTRA | Roy D. BaynesDir | Nov 20 | SPLAN | 1,884 | $224.89 | $424K |
| Natera, Inc. | NTRA | Roy D. BaynesDir | Nov 20 | SPLAN | 1,900 | $223.90 | $425K |
| Natera, Inc. | NTRA | Roy D. BaynesDir | Nov 20 | SPLAN | 1,800 | $222.90 | $401K |
| Natera, Inc. | NTRA | Roy D. BaynesDir | Nov 20 | SPLAN | 900 | $221.81 | $200K |
| Natera, Inc. | NTRA | Roy D. BaynesDir | Nov 20 | SPLAN | 1,184 | $220.14 | $261K |
| Natera, Inc. | NTRA | Roy D. BaynesDir | Nov 20 | MPLAN | 7,068 | $41.19 | $291K |
| Natera, Inc. | NTRA | Roy D. BaynesDir | Nov 20 | MPLAN | 600 | $40.93 | $25K |
| Natera, Inc. | NTRA | Roy D. BaynesDir | Nov 19 | SPLAN | 2,135 | $216.07 | $461K |
| Natera, Inc. | NTRA | Roy D. BaynesDir | Nov 19 | SPLAN | 1,727 | $214.79 | $371K |
| Natera, Inc. | NTRA | Roy D. BaynesDir | Nov 19 | SPLAN | 1,250 | $213.47 | $267K |
| Natera, Inc. | NTRA | Roy D. BaynesDir | Nov 19 | MPLAN | 5,112 | $40.93 | $209K |
| Natera, Inc. | NTRA | Roy D. BaynesDir | Oct 31 | A | 93 | — | — |